Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;3(3):199-204.
doi: 10.4161/derm.3.3.15364. Epub 2011 Jul 1.

Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines

William B Grant  1
Affiliations

Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines

William B Grant. Dermatoendocrinol. 2011 Jul.

Abstract

Ecological studies have reported strong inverse correlations between indices of solar ultraviolet-B (UVB) doses and incidence and/or mortality rates for many types of cancer. Case-control studies (CCS) generally find inverse correlations between serum 25-hydroxyvitamin D [25(OH)D] concentration measured at time of diagnosis for cancer incidence, whereas nested case-control studies (NCCS), which involve a several-year follow-up time after serum sampling, generally do not. This paper examines the relation between follow-up interval and relative risk (RR) for breast, colorectal, and prostate cancer. I plot the RR versus serum 25(OH)D data as a function of follow-up time from the literature for each type of cancer. For breast cancer, RRs were significantly reduced only for follow-up periods less than 3 years. For colorectal cancer, RRs were generally significantly reduced for follow-up periods up to 12 years. For prostate cancer, RRs were not statistically significant from 4 years to 28 years. This study included no CCS. Follow-up periods after serum sampling should not be too long for breast cancer because once a tumor reaches a diameter of 1-3 mm, it requires angiogenesis to continue growing, and vitamin D reduces angiogenesis around tumors. Breast cancer diagnoses are more common in spring and fall than in summer or winter, indicating that they can grow rapidly if circulating 25(OH)D drops in the fall or melatonin levels drop in spring. Serum sampling should be conducted during the study, perhaps every 2 years, to overcome the problem of change of 25(OH)D concentration during cohort studies.

Keywords: breast cancer; case-control studies; colorectal cancer; ecological studies; prostate cancer; ultraviolet-B; vitamin D.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scatter plot of breast cancer RR with respect to follow-up period. The solid line is the linear fit to the RR; the dashed lines are the linear fit to the 95% CIs.
Figure 2
Figure 2
Scatter plot of colorectal cancer RR with respect to follow-up period as in Figure 1.
Figure 3
Figure 3
Scatter plot of prostate cancer RR with respect to follow-up period as in Figure 1.
See this image and copyright information in PMC

References

    1. IOM (Institute of Medicine), author Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press; 2011. - PubMed
    1. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J Clin Endocrinol Metab. 2011;96:53–58. - PMC - PubMed
    1. Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008;88:491–499. - PubMed
    1. Holick MF, editor. Vitamin D; Physiology, Molecular Biology and Clinical Applications. Second Edition. Springer NY: Humana Press; 2010. p. 1155.
    1. Holick MF. Vitamin D: Evolutionary, physiological and health perspectives. Curr Drug Targets. 2011;12:4–18. - PubMed

LinkOut - more resources